Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/08/015221
CTRI/2018/08/015221
Completed
未知

Correlation of Interleukin 28A mRNA expression with herpes viruses in chronic and aggressive periodontitis patients: A polymerase chain reaction study.

DR SHIVAPRASAD BM0 sites90 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Chronic and Aggressive patients

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Chronic and Aggressive patients
Sponsor
DR SHIVAPRASAD BM
Enrollment
90
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 30, 2018
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
DR SHIVAPRASAD BM

Eligibility Criteria

Inclusion Criteria

  • •1 Systematically healthy patients and showing the absence of clinical manifestations of periodontal disease.
  • •2 Chronic periodontitis patients having at least 20 natural teeth and minimum of 6 teeth with periodontal pockets \>\= 5mm and clinical attachment level \>\= 3\-4mm.
  • •3 All the patients should be systematically healthy and should not have received periodontal treatment for last 6 months prior to the clinical examination and sampling.
  • •4 Generalised aggressive periodontitis patients with clinical attachment level \>\= 5mm affecting atleast 3 teeth other than first molars and incisors and moderate to severe bone loss as assessed by radiographs

Exclusion Criteria

  • •2 Systemic diseases like diabetes mellitus, heart diseases, rheumatoid arthritis, hepatitis and other systemic diseases that can alter the course of periodontal disease.
  • •3 Diseases of oral hard and soft tissue except caries and periodontitis.
  • •4 Subjects on any medication taken within last 6 months which may alter the periodontal status.
  • •5 Pregnant and lactating mothers.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Relationship of herpes virus with interleukin in gum diseases
CTRI/2018/07/015141Dr Shivaprasad BM
Completed
Not Applicable
Study to evaluate association of genetic marker IL-28B and cure rates in chronic HCV infection to standard treatmentHealth Condition 1: null- HCV patients
CTRI/2013/02/003428MSD PHARMACEUTICALS PVT LTD1,330
Not yet recruiting
Not Applicable
Correlation of antiviral molecules with viruses in gum diseasesHealth Condition 1: R893- Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues
CTRI/2019/01/016854Dr Shivaprasad BM
Not yet recruiting
Not Applicable
Relationship between levels of Interleukin-1a in gum fluid and the development of root resorption after dental injury.
CTRI/2024/07/070145nithiyalakshmi kanagaraj
Completed
Not Applicable
The correlation of IL28B genotypes with patient demographics and disease characteristics in patients with Genotype 1 chronic hepatitis Chepatitis Cgenotype 1antiviral treatment naiveInfection - Other infectious diseasesHuman Genetics and Inherited Disorders - Other human genetics and inherited disorders
ACTRN12611000846921Australian Liver Association Clinical Trial Network2,000